Keros Therapeutics, Inc. Common Stock
Symbol: KROS (NASDAQ)
15.74
▲ (0.58%) 0.090
Company Description:
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
Key Stats
- Today's Open: $15.67
- Today's High: $15.85
- Today's Low: $15.335
- Today's Volume: 234.96K
- Yesterday Close: $15.65
- Yesterday High: $15.75
- Yesterday Low: $15.23
- Yesterday Volume: 287.75K
- Last Min Volume: 2
- Last Min High: $15.74
- Last Min Low: $15.74
- Last Min VWAP: $15.74
Company Profile
- Name: Keros Therapeutics, Inc. Common Stock
- Website: https://www.kerostx.com
- Listed Date: 2020-04-08
- Location: LEXINGTON, MA
- Market Status: Active
- CIK Number: 0001664710
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $635.63M
- Round Lot: 100
- Outstanding Shares: 40.62M
- Asset Type: CS
RECENT FILINGS FOR KROS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 8-K | View |
| 2025-09-05 | 4 | View |
| 2025-08-28 | 8-K | View |
| 2025-08-21 | SCHEDULE 13D/A | View |
| 2025-08-20 | 8-K | View |
| 2025-08-15 | 3 | View |
| 2025-08-15 | 3 | View |
| 2025-08-06 | 8-K | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-17 | 8-K | View |
| 2025-07-15 | 8-K | View |
| 2025-06-24 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-11 | 4/A | View |
| 2025-06-11 | 4/A | View |
| 2025-06-09 | 8-K | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
Latest News on KROS